141 related articles for article (PubMed ID: 34767797)
1. Ghrelin attenuates transforming growth factor-β1-induced pulmonary fibrosis via the miR-125a-5p/Kruppel-like factor 13 axis.
Qiu J; Ma C; Dai W; Fang E; Li W; Yang F
Arch Biochem Biophys; 2022 Jan; 715():109082. PubMed ID: 34767797
[TBL] [Abstract][Full Text] [Related]
2. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
3. A novel molecular mechanism of microRNA-21 inducing pulmonary fibrosis and human pulmonary fibroblast extracellular matrix through transforming growth factor β1-mediated SMADs activation.
Zhou J; Xu Q; Zhang Q; Wang Z; Guan S
J Cell Biochem; 2018 Sep; 119(9):7834-7843. PubMed ID: 29943845
[TBL] [Abstract][Full Text] [Related]
4. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
Deng W; Zhang Y; Fang P; Shi H; Yang S
Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
[TBL] [Abstract][Full Text] [Related]
5. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L
J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
[TBL] [Abstract][Full Text] [Related]
9. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
10. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
12. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
[TBL] [Abstract][Full Text] [Related]
14. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
15. miR-770-5p inhibits the activation of pulmonary fibroblasts and silica-induced pulmonary fibrosis through targeting TGFBR1.
Yuan J; Li P; Pan H; Xu Q; Xu T; Li Y; Wei D; Mo Y; Zhang Q; Chen J; Ni C
Ecotoxicol Environ Saf; 2021 Sep; 220():112372. PubMed ID: 34082245
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β induced protein regulates pulmonary fibrosis via the G-protein signaling modulator 2 /Snail axis.
Yang K; Huang N; Sun J; Dai W; Chen M; Zeng J
Peptides; 2022 Sep; 155():170842. PubMed ID: 35872259
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of miR-125a-3p promotes fibroblast activation via Fyn/STAT3 pathway during silica-induced pulmonary fibrosis.
Xu Q; Liu Y; Pan H; Xu T; Li Y; Yuan J; Li P; Yao W; Yan W; Ni C
Toxicology; 2019 Feb; 414():57-67. PubMed ID: 30658076
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway.
Zhang Y; Yao XH; Wu Y; Cao GK; Han D
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8483-8492. PubMed ID: 32894569
[TBL] [Abstract][Full Text] [Related]
19. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]